Correlation Between ZyVersa Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Transcode Therapeutics.
Diversification Opportunities for ZyVersa Therapeutics and Transcode Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between ZyVersa and Transcode is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.32 times less risky than Transcode Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 984.00 in Transcode Therapeutics on August 26, 2024 and sell it today you would lose (946.00) from holding Transcode Therapeutics or give up 96.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Transcode Therapeutics |
ZyVersa Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite ZyVersa Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |